Prelude Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Prelude Capital Management’s Portfolio LCTX Stock Details LCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.6K	Buy	+14,942	New	+$25.2K	﹤0.01%	1157
2023 Q2	–	Sell	-16,688	Closed	-$25K	–	1268
2023 Q1	$25K	Buy	+16,688	New	+$23.3K	﹤0.01%	1037
2022 Q4	–	Sell	-11,465	Closed	-$13K	–	1510
2022 Q3	$13K	Buy	+11,465	New	+$16.8K	﹤0.01%	1295
2021 Q2	–	Sell	-17,529	Closed	-$41K	–	1895
2021 Q1	$41K	Buy	+17,529	New	+$42.1K	﹤0.01%	1468
2017 Q4	–	Sell	-4,115	Closed	-$10K	–	1581
2017 Q3	$10K	Buy	4,115 +1,257	+44%	+$3.12K	﹤0.01%	1434
2017 Q2	$8K	Sell	2,858 -31,089	-92%	-$86.9K	﹤0.01%	1426
2017 Q1	$102K	Buy	33,947 +28,918	+575%	+$82.1K	0.01%	776
2016 Q4	$16K	Buy	+5,029	New	+$15.4K	﹤0.01%	1332
2014 Q3	–	Sell	-9,498	Closed	-$23K	–	2018
2014 Q2	$23K	Buy	9,498 +929	+11%	+$2.1K	﹤0.01%	1691
2014 Q1	$23K	Buy	+8,569	New	+$25.2K	﹤0.01%	1643

Other funds holding LCTX

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return

Fifth Third Bancorp

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return